Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Irbesartan/Amlodipine Fixed Combination Therapy Compared With Amlodipine Monotherapy in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy

NCT00956644 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00956644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00956644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Irbesartan/Amlodipine Fixed Combination Therapy Compared With Amlodipine Monotherapy in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2009
Completion date
August 31, 2010
Enrollment
406 (estimated)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension